Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-17 09:35 am Sale |
2025-03-31 | 13G | 4D Molecular Therapeutics, Inc. FDMT |
BLACKROCK INC BLK |
3,615,316 7.800% |
-1,349,703 (-27.18%) |
Filing History |
| 2025-02-14 6:30 pm Sale |
2024-12-31 | 13G | 4D Molecular Therapeutics, Inc. FDMT |
RA Capital Management, L.P. | 4,564,867 9.900% |
-533,344 (-10.46%) |
Filing History |
| 2025-02-14 6:09 pm Sale |
2024-12-31 | 13G | 4D Molecular Therapeutics, Inc. FDMT |
Venrock Healthcare Capital Partners III L.P. | 2,952,371 6.400% |
-1,447,629 (-32.90%) |
Filing History |
| 2025-02-14 4:20 pm Sale |
2024-12-31 | 13G | 4D Molecular Therapeutics, Inc. FDMT |
BIOTECHNOLOGY VALUE FUND L P | 4,834,297 9.990% |
-2,548,345 (-34.52%) |
Filing History |
| 2025-02-14 11:34 am Sale |
2024-12-31 | 13G | 4D Molecular Therapeutics, Inc. FDMT |
JANUS HENDERSON GROUP PLC JHG |
2,252,240 4.900% |
-884,847 (-28.21%) |
Filing History |
| 2025-02-14 08:40 am Sale |
2024-12-31 | 13G | 4D Molecular Therapeutics, Inc. FDMT |
Deep Track Capital, LP | 609,900 1.320% |
-3,486,552 (-85.11%) |
Filing History |
| 2025-02-10 5:28 pm Purchase |
2024-12-31 | 13G | 4D Molecular Therapeutics, Inc. FDMT |
GOLDMAN SACHS GROUP INC GS |
4,423,435 9.600% |
831,575 (+23.15%) |
Filing History |
| 2024-12-06 4:28 pm Purchase |
2024-11-30 | 13G | 4D Molecular Therapeutics, Inc. FDMT |
BLACKROCK INC BLK |
4,965,019 10.700% |
96,230 (+1.98%) |
Filing History |
| 2024-11-15 5:05 pm Sale |
2024-11-13 | 13G | 4D Molecular Therapeutics, Inc. FDMT |
RA Capital Management, L.P. | 5,098,211 11.000% |
-103,934 (-2.00%) |
Filing History |
| 2024-11-14 5:46 pm Purchase |
2024-09-30 | 13G | 4D Molecular Therapeutics, Inc. FDMT |
RA Capital Management, L.P. | 5,202,145 9.990% |
1,038,934 (+24.96%) |
Filing History |
| 2024-11-14 4:31 pm Sale |
2024-09-30 | 13G | 4D Molecular Therapeutics, Inc. FDMT |
VIKING GLOBAL INVESTORS LP | 0 0.000% |
-4,247,914 (Position Closed) |
Filing History |
| 2024-11-14 3:15 pm Purchase |
2024-09-30 | 13G | 4D Molecular Therapeutics, Inc. FDMT |
JANUS HENDERSON GROUP PLC JHG |
3,137,087 6.000% |
43,791 (+1.42%) |
Filing History |
| 2024-11-14 09:13 am Purchase |
2024-09-30 | 13G | 4D Molecular Therapeutics, Inc. FDMT |
Deep Track Capital, LP | 4,096,452 7.880% |
1,812,080 (+79.33%) |
Filing History |
| 2024-11-13 4:08 pm Purchase |
2024-09-30 | 13G | 4D Molecular Therapeutics, Inc. FDMT |
BIOTECHNOLOGY VALUE FUND L P | 7,382,642 14.200% |
3,375,229 (+84.22%) |
Filing History |
| 2024-11-12 12:12 pm Unchanged |
2024-09-30 | 13G | 4D Molecular Therapeutics, Inc. FDMT |
The Vanguard Group | 2,767,717 5.320% |
0 (Unchanged) |
Filing History |
| 2024-11-08 2:17 pm Unchanged |
2024-09-30 | 13G | 4D Molecular Therapeutics, Inc. FDMT |
BLACKROCK INC BLK |
4,868,789 9.400% |
0 (Unchanged) |
Filing History |
| 2024-11-06 6:07 pm Purchase |
2024-09-30 | 13G | 4D Molecular Therapeutics, Inc. FDMT |
GOLDMAN SACHS GROUP INC GS |
3,591,860 6.900% |
3,591,860 (New Position) |
Filing History |
| 2024-11-04 10:55 am Purchase |
2024-09-30 | 13G | 4D Molecular Therapeutics, Inc. FDMT |
The Vanguard Group | 2,767,717 5.320% |
2,767,717 (New Position) |
Filing History |
| 2024-10-21 4:11 pm Purchase |
2024-09-30 | 13G | 4D Molecular Therapeutics, Inc. FDMT |
BLACKROCK INC BLK |
4,868,789 9.400% |
1,404,202 (+40.53%) |
Filing History |
| 2024-02-14 8:51 pm Purchase |
2023-12-31 | 13G | 4D Molecular Therapeutics, Inc. FDMT |
Venrock Healthcare Capital Partners III L.P. | 4,400,000 8.900% |
1,512,483 (+52.38%) |
Filing History |